Physician
Michumi PLLC
Michumi PLLC was paid $12.39M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoMICHUMI PLLC
WILLIAMSBURG, VA 23185
WILLIAMSBURG, VA 23185
33aNPI1255388021assigned 05/27/2006
33bProvider typeEmergency Medicine Physician
28Total paid$12.39M
24GClaims261,572
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Virginia
Rank by total paid#6 of 447
Median peer was paid$6K
This provider vs. median2,178×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,393 | $971K | |
| 2019 | 37,671 | $1.55M | |
| 2020 | 31,363 | $1.27M | |
| 2021 | 36,256 | $1.59M | |
| 2022 | 38,643 | $2.08M | |
| 2023 | 49,480 | $2.61M | |
| 2024incomplete | 45,766 | $2.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 63,732 | 60,450 | $3.63M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 41,631 | 39,097 | $3.17M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 17% | 29,391 | 28,026 | $2.11M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 9.3% | 10,199 | 9,701 | $1.15M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.8% | 6,634 | 6,272 | $720K |
| 87428 | 3.0% | 10,613 | 10,151 | $371K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 9,057 | 8,751 | $251K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 18,396 | 8,720 | $231K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 17,510 | 16,758 | $226K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,914 | 1,871 | $96K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,151 | 2,072 | $70K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,460 | 1,401 | $62K |
33 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,923 | $57K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,198 | $54K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,507 | $52K |
| 87905 | <1% | 1,917 | $22K | |
| 81025 | <1% | 3,215 | $22K | |
| 99000 | <1% | 13,685 | $21K | |
| 81003 | <1% | 11,195 | $17K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,485 | $11K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 469 | $7K |
| 87808 | <1% | 994 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,776 | $6K |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 137 | $5K |
| 73630 | <1% | 203 | $5K | |
| 73610 | <1% | 176 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 272 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,027 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 280 | $2K |
| 93000 | <1% | 183 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 159 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 618 | $945.02 |
| 73130 | <1% | 30 | $863.13 | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 13 | $825.00 |
| 73560 | <1% | 14 | $425.46 | |
| L3260 | Surgical boot/shoe, each | <1% | 12 | $404.04 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 295 | $373.33 |
| 86308 | <1% | 38 | $204.38 | |
| 80076 | <1% | 64 | $165.86 | |
| 82977 | <1% | 64 | $138.96 | |
| 82150 | <1% | 64 | $124.72 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 145 | $52.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 433 | $48.91 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 200 | $41.26 |
| 36416 | <1% | 93 | $33.22 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, BRADEN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Peninsula Cancer Institute, LLC | Newport News, VA | $922K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.